1. Home
  2. LEGN vs BROS Comparison

LEGN vs BROS Comparison

Compare LEGN & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • BROS
  • Stock Information
  • Founded
  • LEGN 2014
  • BROS 1992
  • Country
  • LEGN United States
  • BROS United States
  • Employees
  • LEGN N/A
  • BROS N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • BROS Restaurants
  • Sector
  • LEGN Health Care
  • BROS Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • BROS Nasdaq
  • Market Cap
  • LEGN 7.0B
  • BROS 7.6B
  • IPO Year
  • LEGN 2020
  • BROS 2021
  • Fundamental
  • Price
  • LEGN $28.39
  • BROS $65.45
  • Analyst Decision
  • LEGN Strong Buy
  • BROS Strong Buy
  • Analyst Count
  • LEGN 13
  • BROS 15
  • Target Price
  • LEGN $75.67
  • BROS $78.27
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • BROS 2.9M
  • Earning Date
  • LEGN 05-13-2025
  • BROS 05-07-2025
  • Dividend Yield
  • LEGN N/A
  • BROS N/A
  • EPS Growth
  • LEGN N/A
  • BROS 109.32
  • EPS
  • LEGN N/A
  • BROS 0.38
  • Revenue
  • LEGN $728,303,000.00
  • BROS $1,361,068,000.00
  • Revenue This Year
  • LEGN $65.96
  • BROS $26.31
  • Revenue Next Year
  • LEGN $52.55
  • BROS $23.86
  • P/E Ratio
  • LEGN N/A
  • BROS $191.83
  • Revenue Growth
  • LEGN 112.46
  • BROS 30.42
  • 52 Week Low
  • LEGN $29.27
  • BROS $26.96
  • 52 Week High
  • LEGN $60.87
  • BROS $86.88
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 37.61
  • BROS 52.54
  • Support Level
  • LEGN $27.34
  • BROS $58.20
  • Resistance Level
  • LEGN $33.30
  • BROS $73.93
  • Average True Range (ATR)
  • LEGN 1.90
  • BROS 2.59
  • MACD
  • LEGN -0.28
  • BROS 0.45
  • Stochastic Oscillator
  • LEGN 17.19
  • BROS 51.78

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.

Share on Social Networks: